March 2006: Agreement Cements Unique Liposomal Formulation
Bridge to Life Preservation Solutions Ltd., Milwaukee, Wisconsin, announced an agreement with Vitatech of Louisville, Kentucky, to license Vitatech’s liposomal formulation containing adenosine triphosphate (ATP), which provides energy to living cells.
Bridge to Life has licensed VitaTech’s patent-pending technology to directly infuse cells with energy. Specially engineered vesicles containing ATP are made to fuse with the cell membrane, quickly and efficiently transferring the energy. This allows cells to maintain their function, even in the absence of oxygen. The result is superior preservation, growth, and healing.
Bridge to Life CEO, Stevan Schweighardt, and Vitatech CEO, Patrick Migliore jointly announced the agreement.
For further details, visit our Research section.